Dr. Belma Turan is Professor of Biophysics, Faculty of Medicine at the Ankara University, Ankara, Turkey. Her research interest and expertise include electrophysiology of cardiovascular system, intracellular ion homeostasis, oxidative stress as well as antioxidant defense with respect to gender difference and diabetic cardiomyopathy. She has been engaged in teaching and research in heath and disease for the past 25 years.Dr. Naranjan Dhalla is Distinguished Professor at the University of Manitoba, Winnipeg, Canada. His expertise includes the subcellular and molecular basis of heart function in health and disease. He has been engaged in multidisciplinary research in ischemic heart disease and heart failure as well as education for promoting scientific basis cardiology and training of professional manpower for combating heart disease for over 40 years.

From the book reviews: "Cardiovascular disease occurs also, but rarely, in late adolescence and young adults, depending on age at onset of disease and degree of metabolic control. Thus, this well referenced and up to date text is mainly of interest to adult diabetologists , cardiologists and researchers." (Pediatric Endocrinology Reviews (PER), Vol. 12 (1), September, 2014)

• Cardiac defects in diabetes.- Hormonal imbalance and neuropathy.- Role of oxidative stress.- Role of cation channel defects.- Abnormalities in glucose transport.- Fatty acid utilization.- Sarcolemmal Na+-K+ ATPase.- Sarcolemmal Ca2+-transport.- Sarcoplasmic reticular Ca2+-transport.- Intracellular Ca2+-homeostasis.- Mitochondrial function.- Contractile proteins.- β-adrenoceptor mechanisms.- Protein kinases and signal transduction.- Regulation of phopholipases.- Endothelin defects and cardiac dysfunction.- Metabolic changes in smooth muscles.- Metabolic defects in skeletal muscles.- Metabolic defects in brain.- Role of microangiopathy in heart dysfunction.- Role of nephropathy in heart dysfunction.- Prevention of diabetic-induced cardiac dysfunction.- Molecular targets for the therapy of diabetic cardiomyopathy.

Dr. Belma Turan is Professor of Biophysics, Faculty of Medicine at the Ankara University, Ankara, Turkey. Her research interest and expertise include electrophysiology of cardiovascular system, intracellular ion homeostasis, oxidative stress as well as antioxidant defense with respect to gender difference and diabetic cardiomyopathy. She has been engaged in teaching and research in heath and disease for the past 25 years.Dr. Naranjan Dhalla is Distinguished Professor at the University of Manitoba, Winnipeg, Canada. His expertise includes the subcellular and molecular basis of heart function in health and disease. He has been engaged in multidisciplinary research in ischemic heart disease and heart failure as well as education for promoting scientific basis cardiology and training of professional manpower for combating heart disease for over 40 years.

From the book reviews: "Cardiovascular disease occurs also, but rarely, in late adolescence and young adults, depending on age at onset of disease and degree of metabolic control. Thus, this well referenced and up to date text is mainly of interest to adult diabetologists , cardiologists and researchers." (Pediatric Endocrinology Reviews (PER), Vol. 12 (1), September, 2014)

• Cardiac defects in diabetes.- Hormonal imbalance and neuropathy.- Role of oxidative stress.- Role of cation channel defects.- Abnormalities in glucose transport.- Fatty acid utilization.- Sarcolemmal Na+-K+ ATPase.- Sarcolemmal Ca2+-transport.- Sarcoplasmic reticular Ca2+-transport.- Intracellular Ca2+-homeostasis.- Mitochondrial function.- Contractile proteins.- β-adrenoceptor mechanisms.- Protein kinases and signal transduction.- Regulation of phopholipases.- Endothelin defects and cardiac dysfunction.- Metabolic changes in smooth muscles.- Metabolic defects in skeletal muscles.- Metabolic defects in brain.- Role of microangiopathy in heart dysfunction.- Role of nephropathy in heart dysfunction.- Prevention of diabetic-induced cardiac dysfunction.- Molecular targets for the therapy of diabetic cardiomyopathy.